Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer.
暂无分享,去创建一个
[1] V. E. Fadouloglou,et al. Identification of a peptide ligand for human ALDH3A1 through peptide phage display: Prediction and characterization of protein interaction sites and inhibition of ALDH3A1 enzymatic activity , 2023, Frontiers in Molecular Biosciences.
[2] H. Issa,et al. In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin , 2023, Current issues in molecular biology.
[3] Lixing Zhang,et al. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets , 2023, MedComm.
[4] Aglaia Pappa,et al. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression , 2023, Life.
[5] L. Fu,et al. The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer. , 2022, Clinical breast cancer.
[6] L. Holm,et al. DALI shines a light on remote homologs: One hundred discoveries , 2022, Protein science : a publication of the Protein Society.
[7] Chundi Gao,et al. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment , 2022, BioMed research international.
[8] C. Kuo,et al. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1 , 2022, Nature Chemical Biology.
[9] M. Kumar,et al. 3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation , 2022, Archiv der Pharmazie.
[10] Mu-Kuan Chen,et al. The impact of ALDH7A1 variants in oral cancer development and prognosis , 2022, Aging.
[11] C. Arienti,et al. Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance , 2022, Frontiers in Medicine.
[12] X. Piao,et al. Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention , 2022, International journal of molecular sciences.
[13] N. Maitland,et al. Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer , 2022, Journal of medicinal chemistry.
[14] X. Zhan,et al. Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers , 2021, Oxidative medicine and cellular longevity.
[15] C. Camacho,et al. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells , 2021, Communications Biology.
[16] Z. Shao,et al. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression , 2021, Cancer Research.
[17] J. Farrés,et al. Design, Synthesis, Biological Evaluation and In Silico Study of Benzyloxybenzaldehyde Derivatives as Selective ALDH1A3 Inhibitors , 2021, Molecules.
[18] M. Matúšková,et al. Aldehyde dehydrogenase 1A1 and 1A3 isoforms – mechanism of activation and regulation in cancer , 2021, Cellular signalling.
[19] J. Haybaeck,et al. Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition. , 2021, Lung cancer.
[20] N. Chandel. NADPH-The Forgotten Reducing Equivalent. , 2021, Cold Spring Harbor perspectives in biology.
[21] V. E. Fadouloglou,et al. Post-Translational Modifications: Host Defence Mechanism, Pathogenic Weapon, and Emerged Target of Anti-Infective Drugs , 2021, Frontiers in Anti-Infective Drug Discovery: Volume 9.
[22] A. Djeghader,et al. Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective , 2021, Frontiers in Molecular Biosciences.
[23] D. Hong,et al. Reply to Krupenko et al., Comment on “Lee et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer Cancers 2020, 12, 1382” , 2021, Cancers.
[24] P. Bork,et al. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation , 2021, Nucleic Acids Res..
[25] H. Jang,et al. Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse , 2021, Theranostics.
[26] E. Aronica,et al. A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro , 2021, Cancers.
[27] T. Missihoun,et al. Recent Development on Plant Aldehyde Dehydrogenase Enzymes and Their Functions in Plant Development and Stress Signaling , 2020, Genes.
[28] Ying Lin,et al. Perinatal Depression of Exposed Maternal Women in the COVID-19 Pandemic in Wuhan, China , 2020, Frontiers in Psychiatry.
[29] C. La Motta,et al. Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target , 2020, Biomedicines.
[30] J. Tanner,et al. Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1. , 2020, Archives of biochemistry and biophysics.
[31] M. Kokkinidis,et al. Catalytic activity regulation through post-translational modification: the expanding universe of protein diversity , 2020, Advances in Protein Chemistry and Structural Biology.
[32] Soo-Youl Kim,et al. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer , 2020, Cancers.
[33] John N. Hutchinson,et al. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers. , 2020, Blood.
[34] C. La Motta,et al. Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells. , 2020, Journal of medicinal chemistry.
[35] C. La Motta,et al. Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family. , 2020, ACS medicinal chemistry letters.
[36] F. Ursini,et al. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. , 2020, Free radical biology & medicine.
[37] Wei Wu,et al. Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma , 2020, Translational oncology.
[38] Y. Osuga,et al. Expression of ALDH1A Isozymes in Human Endometrium with and without Endometriosis and in Ovarian Endometrioma , 2020, Reproductive Sciences.
[39] S. Donnini,et al. ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output , 2019, Cancers.
[40] N. Dokholyan,et al. Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent , 2019, Molecular Cancer Therapeutics.
[41] H. Younus,et al. Citral Inhibition of Human Salivary Aldehyde Dehydrogenase , 2019, Cell Biochemistry and Biophysics.
[42] Y. Rojanasakul,et al. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer , 2019, Molecular and Cellular Biology.
[43] N. Nordin,et al. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity , 2019, Molecules.
[44] G. Moreno-Hagelsieb,et al. Aldehyde dehydrogenase diversity in bacteria of the Pseudomonas genus. , 2019, Chemico-biological interactions.
[45] L. Galluzzi,et al. Metabolic enzymes expressed by cancer cells impact the immune infiltrate , 2019, Oncoimmunology.
[46] E. Yoon,et al. A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells. , 2019, Cell reports.
[47] H. Rodemann,et al. Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells , 2019, International journal of molecular sciences.
[48] P. Bradshaw. Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging , 2019, Nutrients.
[49] K. Fink,et al. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma , 2019, Journal of Neuro-Oncology.
[50] M. J. Masarudin,et al. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells , 2019, Scientific Reports.
[51] R. Moreno-Sánchez,et al. Role of Aldehyde Dehydrogenases in Physiopathological Processes. , 2019, Chemical research in toxicology.
[52] Amaj Ahmed Laskar,et al. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis , 2019, Drug metabolism reviews.
[53] J. Tanner,et al. Crystal Structure of Aldehyde Dehydrogenase 16 Reveals Trans-Hierarchical Structural Similarity and a New Dimer. , 2019, Journal of molecular biology.
[54] D. Adams,et al. ALDH1 Bio-activates Nifuroxazide to Eradicate ALDHHigh Melanoma-Initiating Cells , 2018, Cell chemical biology.
[55] Wei Ma,et al. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay , 2018, Cell Biology and Toxicology.
[56] Geeta Mehta,et al. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy. , 2018, Journal of medicinal chemistry.
[57] S. Okazaki,et al. Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells , 2018, Oncotarget.
[58] H. Eguchi,et al. The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer. , 2018, Oncology letters.
[59] S. Ohdo,et al. Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor. , 2018, Cancer research.
[60] S. Darb-Esfahani,et al. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis. , 2018, Gynecologic oncology.
[61] M. Matúšková,et al. ALDH1A inhibition sensitizes colon cancer cells to chemotherapy , 2018, BMC Cancer.
[62] Adam Yasgar,et al. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity , 2018, Journal of medicinal chemistry.
[63] Chunfu Wu,et al. Suppressing autophagy enhances disulfiram/copper‐induced apoptosis in non‐small cell lung cancer , 2018, European journal of pharmacology.
[64] F. Feng,et al. Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis , 2018, OncoTargets and therapy.
[65] J. Loscalzo,et al. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. , 2018, Antioxidants & redox signaling.
[66] C. Jeffery. Protein moonlighting: what is it, and why is it important? , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.
[67] H. Ishii,et al. Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis , 2018, Scientific Reports.
[68] Xiangchou Yang,et al. Update of ALDH as a Potential Biomarker and Therapeutic Target for AML , 2018, BioMed research international.
[69] P. Eyers,et al. Live and let die: insights into pseudoenzyme mechanisms from structure. , 2017, Current opinion in structural biology.
[70] J. P. Loria,et al. Allostery in enzyme catalysis. , 2017, Current opinion in structural biology.
[71] Jiri Bartek,et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4 , 2017, Nature.
[72] Jong-Hee Chang,et al. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres , 2017, Neuro-oncology.
[73] P. Mackenzie,et al. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species. , 2017, Biochemical pharmacology.
[74] Hongyu Zhao,et al. Transcriptomic analysis and plasma metabolomics in Aldh16a1-null mice reveals a potential role of ALDH16A1 in renal function. , 2017, Chemico-biological interactions.
[75] M. Gasparetto,et al. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers. , 2017, Chemico-biological interactions.
[76] R. Franco,et al. Human aldehyde dehydrogenase 3A1 (ALDH3A1) exhibits chaperone-like function. , 2017, The international journal of biochemistry & cell biology.
[77] S. Tenbaum,et al. ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment , 2017, Oncogene.
[78] M. Salaspuro,et al. ALDH2‐deficiency as genetic epidemiologic and biochemical model for the carcinogenicity of acetaldehyde , 2017, Regulatory toxicology and pharmacology : RTP.
[79] Junwen Wang,et al. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma , 2017, bioRxiv.
[80] Jeewon Kim,et al. Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor , 2017, Oncotarget.
[81] E. Anderson,et al. Biogenic Aldehydes as Therapeutic Targets for Cardiovascular Disease , 2017, Current opinion in pharmacology.
[82] X. Wang,et al. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer , 2017, Cancer biology & therapy.
[83] Che-Hong Chen,et al. ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective , 2017, Journal of Biomedical Science.
[84] Priyanka Chevour,et al. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition , 2017, Molecular carcinogenesis.
[85] David W. Lee,et al. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells , 2017, Journal of experimental & clinical cancer research : CR.
[86] C. La Motta,et al. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells. , 2016, Cancer research.
[87] P. Marcato,et al. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3 , 2016, Molecular oncology.
[88] M. Duchen,et al. Investigating mitochondrial redox state using NADH and NADPH autofluorescence , 2016, Free radical biology & medicine.
[89] B. Mayer,et al. Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin* , 2016, The Journal of Biological Chemistry.
[90] Komaraiah Palle,et al. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. , 2016, Annals of translational medicine.
[91] C. Pirker,et al. Anticancer metal drugs and immunogenic cell death. , 2016, Journal of inorganic biochemistry.
[92] T. Yeh,et al. ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients , 2016, Clinical Cancer Research.
[93] Jihe Zhao. Cancer stem cells and chemoresistance: The smartest survives the raid. , 2016, Pharmacology & therapeutics.
[94] Kaori Tanaka,et al. Aldehyde dehydrogenase 1A1 in stem cells and cancer , 2016, Oncotarget.
[95] Yiming Yang,et al. Aldehyde dehydrogenases and cancer stem cells. , 2015, Cancer letters.
[96] Brian C. Jackson,et al. Dead enzymes in the aldehyde dehydrogenase gene family: role in drug metabolism and toxicology , 2015, Expert opinion on drug metabolism & toxicology.
[97] M. Baumann,et al. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma , 2015, Oncotarget.
[98] M. Ferrer,et al. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1). , 2015, Journal of medicinal chemistry.
[99] Kaori Tanaka,et al. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma , 2015, Oncotarget.
[100] G. Robertson,et al. Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway , 2015, Molecular Cancer Research.
[101] C. Buchman,et al. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes. , 2015, Chemico-biological interactions.
[102] E. Morii,et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. , 2015, Gynecologic oncology.
[103] T. Peretz,et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. , 2015, The oncologist.
[104] M. Wirth,et al. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. , 2015, Cancer research.
[105] You-hong Cui,et al. Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. , 2015, American journal of cancer research.
[106] T. Hurley,et al. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. , 2015, Journal of medicinal chemistry.
[107] B. Liu,et al. Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma , 2015, Oncotarget.
[108] J. Tanner,et al. Diethylaminobenzaldehyde is a covalent, irreversible inactivator of ALDH7A1. , 2015, ACS chemical biology.
[109] Y. Xiong,et al. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. , 2014, The Journal of clinical investigation.
[110] J. Moreb,et al. Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development? , 2014, Drug discovery today.
[111] In Gyu Kim,et al. Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases γ-radiation-induced sensitivity in some pancreatic cancer cell lines. , 2014, Biochemical and biophysical research communications.
[112] V. Thiviyanathan,et al. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas , 2014, International journal of oncology.
[113] S. Sieber,et al. Target discovery of acivicin in cancer cells elucidates its mechanism of growth inhibition , 2014, Chemical science.
[114] F. Bertucci,et al. Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib , 2014, PloS one.
[115] R. LoPachin,et al. Molecular Mechanisms of Aldehyde Toxicity: A Chemical Perspective , 2014, Chemical research in toxicology.
[116] John D. Minna,et al. Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway , 2014, Clinical Cancer Research.
[117] D. Matei,et al. Beta-Catenin Regulated ALDH1A1 is a Target in Ovarian Cancer Spheroids , 2014, Oncogene.
[118] Bo Wang,et al. Enrichment of Chemical Libraries Docked to Protein Conformational Ensembles and Application to Aldehyde Dehydrogenase 2 , 2014, J. Chem. Inf. Model..
[119] R. Schmid,et al. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity , 2014, BMC Cancer.
[120] V. Vasiliou,et al. Aldehyde dehydrogenases in acute myeloid leukemia , 2014, Annals of the New York Academy of Sciences.
[121] M. Fishel,et al. Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity , 2014, Chembiochem : a European journal of chemical biology.
[122] J. Ajani,et al. ALDH‐1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients , 2014, Molecular oncology.
[123] N. Magné,et al. Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation , 2014, Stem Cell Reviews and Reports.
[124] Daria Mochly-Rosen,et al. Development of Selective Inhibitors for Aldehyde Dehydrogenases Based on Substituted Indole-2,3-diones , 2014, Journal of medicinal chemistry.
[125] M. Fishel,et al. Selective ALDH3A1 Inhibition by Benzimidazole Analogues Increase Mafosfamide Sensitivity in Cancer Cells , 2014, Journal of medicinal chemistry.
[126] K. Ramana,et al. 4-Hydroxynonenal in the pathogenesis and progression of human diseases. , 2013, Current medicinal chemistry.
[127] X. Xie,et al. ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy , 2013, British Journal of Cancer.
[128] M. Zabel,et al. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[129] J. Babich,et al. The Role of Copper in Disulfiram-Induced Toxicity and Radiosensitization of Cancer Cells , 2013, The Journal of Nuclear Medicine.
[130] Taro Saito,et al. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology , 2013, Histochemistry and Cell Biology.
[131] P. Massion,et al. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma. , 2013, Future oncology.
[132] P. Benos,et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 , 2013, Proceedings of the National Academy of Sciences.
[133] Brian C. Jackson,et al. Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. , 2013, Free radical biology & medicine.
[134] Ying Chen,et al. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. , 2013, Chemico-biological interactions.
[135] G. Fournet,et al. α,β-Acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosis. , 2013, Current medicinal chemistry.
[136] M. Miyazaki,et al. Aldehyde dehydrogenase 1 is associated with recurrence‐free survival but not stem cell‐like properties in hepatocellular carcinoma , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.
[137] M. McCarter,et al. ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets , 2012, Stem cells.
[138] G. Oberdorfer,et al. Vascular Bioactivation of Nitroglycerin by Aldehyde Dehydrogenase-2 , 2012, The Journal of Biological Chemistry.
[139] Vindhya Koppaka,et al. Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker. , 2012, Experimental eye research.
[140] A. Pession,et al. Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma , 2012, Advances in Therapy.
[141] Chin-Lee Wu,et al. Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[142] R. Berkowitz,et al. Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures , 2012, BMC Cancer.
[143] Vindhya Koppaka,et al. Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application , 2012, Pharmacological Reviews.
[144] R. Stanton. Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survival , 2012, IUBMB life.
[145] Alysha K Croker,et al. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells , 2012, Breast Cancer Research and Treatment.
[146] C. Brocker,et al. Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development. , 2012, Experimental hematology.
[147] Yu‐Chi Wang,et al. Tumorigenesis and Neoplastic Progression ALDH 1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD 44 Expression , Drug Resistance , and Poor Clinical Outcome , 2012 .
[148] G. Muzio,et al. Aldehyde dehydrogenases and cell proliferation. , 2012, Free radical biology & medicine.
[149] Lung-Ji Chang,et al. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. , 2012, Chemico-biological interactions.
[150] H. Stefánsson,et al. Identification of low-frequency variants associated with gout and serum uric acid levels , 2011, Nature Genetics.
[151] Daria Mochly-Rosen,et al. Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases* , 2011, The Journal of Biological Chemistry.
[152] W. Keung,et al. Differential Metabolism of Organic Nitrates by Aldehyde Dehydrogenase 1a1 and 2: Substrate Selectivity, Enzyme Inactivation, and Active Cysteine Sites , 2011, The AAPS Journal.
[153] L. Tentori,et al. Mutation Research/fundamental and Molecular Mechanisms of Mutagenesis Common Fragile Sites in Colon Cancer Cell Lines: Role of Mismatch Repair, Rad51 and Poly(adp-ribose) Polymerase-1 , 2022 .
[154] M. Koch,et al. Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer , 2011, BMC Cancer.
[155] G. van der Pluijm,et al. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis , 2011, Clinical & Experimental Metastasis.
[156] A. Allan,et al. The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells , 2011, Stem Cell Reviews and Reports.
[157] C. Brocker,et al. Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicity. , 2011, Chemico-biological interactions.
[158] Siddikuzzaman,et al. All Trans Retinoic Acid and Cancer , 2011, Immunopharmacology and immunotoxicology.
[159] Brian C. Jackson,et al. Update on the aldehyde dehydrogenase gene (ALDH) superfamily , 2011, Human Genomics.
[160] Surendra Singh,et al. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. , 2011, Biochemical and biophysical research communications.
[161] Laura A. Sullivan,et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. , 2010, Cancer research.
[162] J. Yustein,et al. High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition , 2010, PloS one.
[163] C. Eaves,et al. Human Milk Protein Production in Xenografts of Genetically Engineered Bovine Mammary Epithelial Stem Cells , 2010, PloS one.
[164] R. Bast,et al. Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer , 2010, Molecular Cancer Therapeutics.
[165] Z. Rasheed,et al. Isolation of Stem Cells from Human Pancreatic Cancer Xenografts , 2010, Journal of visualized experiments : JoVE.
[166] Manuel Hidalgo,et al. Tumor-initiating cells are rare in many human tumors. , 2010, Cell stem cell.
[167] C. Brocker,et al. Aldehyde Dehydrogenase 3B1 (ALDH3B1): Immunohistochemical Tissue Distribution and Cellular-specific Localization in Normal and Cancerous Human Tissues , 2010 .
[168] M. Wicha,et al. Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase , 2010, Head & neck.
[169] R. Fiorelli,et al. A novel classification of quiescent and transit amplifying adult neural stem cells by surface and metabolic markers permits a defined simultaneous isolation. , 2010, Stem cell research.
[170] F. Hamdy,et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. , 2010, Cancer research.
[171] Lin Zhang,et al. Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers , 2010, PloS one.
[172] K. Kavanagh,et al. Aldehyde Dehydrogenase 7A1 (ALDH7A1) Is a Novel Enzyme Involved in Cellular Defense against Hyperosmotic Stress* , 2010, The Journal of Biological Chemistry.
[173] V. Laudet,et al. From carrot to clinic: an overview of the retinoic acid signaling pathway , 2010, Cellular and Molecular Life Sciences.
[174] J. Parry,et al. The in vitro genotoxicity of ethanol and acetaldehyde. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[175] Zhenqiu Liu,et al. ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome , 2009, Laboratory Investigation.
[176] V. Vasiliou,et al. The Aldehyde Dehydrogenase Gene Superfamily Resource Center , 2009, Human Genomics.
[177] D. Overstreet,et al. A selective ALDH-2 inhibitor reduces anxiety in rats , 2009, Pharmacology Biochemistry and Behavior.
[178] D. Steindler,et al. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. , 2009, Cancer research.
[179] D. Moscatelli,et al. High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells , 2009, Stem cells.
[180] Yi-Wei Chen,et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.
[181] Tao Zhang,et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.
[182] Feng Jiang,et al. Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.
[183] C. Blackstone,et al. Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1 , 2009, neurogenetics.
[184] H. Baker,et al. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells , 2008, Molecular Cancer.
[185] K. Chan,et al. Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.
[186] C. Brocker,et al. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily , 2008, Expert opinion on drug metabolism & toxicology.
[187] V. Vasiliou,et al. The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. , 2008, Seminars in cell & developmental biology.
[188] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[189] Vasilis Vasiliou,et al. Multiple and Additive Functions of ALDH3A1 and ALDH1A1 , 2007, Journal of Biological Chemistry.
[190] V. Vasiliou,et al. Mechanisms Involved in the Protection of UV-induced Protein Inactivation by the Corneal Crystallin ALDH3A1* , 2007, Journal of Biological Chemistry.
[191] Q Ping Dou,et al. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. , 2006, Cancer research.
[192] Vasilis Vasiliou,et al. Scallop lens Ω-crystallin (ALDH1A9): A novel tetrameric aldehyde dehydrogenase , 2006 .
[193] S. Shibutani,et al. Increased DNA damage in ALDH2-deficient alcoholics. , 2006, Chemical research in toxicology.
[194] J. Moreb,et al. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide , 2006, Cancer Chemotherapy and Pharmacology.
[195] Y. Koutalos,et al. Human Aldehyde Dehydrogenase 3A1 Inhibits Proliferation and Promotes Survival of Human Corneal Epithelial Cells* , 2005, Journal of Biological Chemistry.
[196] Vasilis Vasiliou,et al. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family , 2005, Human Genomics.
[197] T. Lister,et al. Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples , 2005, Stem cells.
[198] D. Mohuczy,et al. Retinoic Acid Down-Regulates Aldehyde Dehydrogenase and Increases Cytotoxicity of 4-Hydroperoxycyclophosphamide and Acetaldehyde , 2005, Journal of Pharmacology and Experimental Therapeutics.
[199] A. Siraki,et al. Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health , 2005, Critical reviews in toxicology.
[200] M. Picklo,et al. Metabolism of 4-hydroxy-trans-2-nonenal by central nervous system mitochondria is dependent on age and NAD+ availability. , 2004, Chemical research in toxicology.
[201] P. Chambon,et al. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[202] Y. Koutalos,et al. Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. , 2003, Free radical biology & medicine.
[203] R. V. van Montfort,et al. Crystal structure of eta-crystallin: adaptation of a class 1 aldehyde dehydrogenase for a new role in the eye lens. , 2003, Biochemistry.
[204] Timothy A J Haystead,et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome. , 2002, Molecular pharmacology.
[205] U. Reichert,et al. Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2). , 2002, Biochemical pharmacology.
[206] J. Stamler,et al. Identification of the enzymatic mechanism of nitroglycerin bioactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[207] J. Piatigorsky. Enigma of the Abundant Water-Soluble Cytoplasmic Proteins of the Cornea: The “Refracton” Hypothesis , 2001, Cornea.
[208] R. Grafström,et al. Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes , 2001, Cellular and Molecular Life Sciences CMLS.
[209] F. Gabreëls,et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. , 2001, Brain : a journal of neurology.
[210] M. Kirsch,et al. NAD(P)H, a directly operating antioxidant? , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[211] Z. Kozmík,et al. Omega -crystallin of the scallop lens. A dimeric aldehyde dehydrogenase class 1/2 enzyme-crystallin. , 2000, The Journal of biological chemistry.
[212] V. Vasiliou,et al. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. , 2000, Chemico-biological interactions.
[213] E. Sausville,et al. Identification of cytosolic aldehyde dehydrogenase 1 from non‐small cell lung carcinomas as a flavopiridol‐binding protein , 1999, FEBS letters.
[214] P. Chambon,et al. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development , 1999, Nature Genetics.
[215] K. Yamauchi,et al. Xenopus Cytosolic Thyroid Hormone-binding Protein (xCTBP) Is Aldehyde Dehydrogenase Catalyzing the Formation of Retinoic Acid* , 1999, The Journal of Biological Chemistry.
[216] T. Møller-Pedersen,et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. , 1999, Journal of cell science.
[217] H. Baker,et al. Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. , 1998, Structure.
[218] J. Piatigorsky,et al. Multifunctional Lens Crystallins and Corneal Enzymes: More than Meets the Eye , 1998, Annals of the New York Academy of Sciences.
[219] J. Lipsky,et al. Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. , 1997, Biochemistry.
[220] C. G. Steinmetz,et al. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. , 1997, Structure.
[221] L. López-Fernández,et al. The cytosolic aldehyde dehydrogenase gene (Aldh1) is developmentally expressed in Leydig cells , 1997, FEBS letters.
[222] Yuh-Ju Sun,et al. The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold , 1997, Nature Structural Biology.
[223] H. Weiner,et al. Binding of thyroxine analogs to human liver aldehyde dehydrogenases. , 1997, European journal of biochemistry.
[224] E. Khairallah,et al. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. , 1996, Toxicology and applied pharmacology.
[225] D. Crabb,et al. The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion. , 1996, The Journal of clinical investigation.
[226] D. Balasubramanian,et al. Letter to the Editors: Corneal Aldehyde Dehydrogenase Displays Antioxidant Properties , 1996 .
[227] A. Klyosov,et al. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. , 1996, Biochemistry.
[228] M. Gariboldi,et al. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines. , 1994, Molecular pharmacology.
[229] H. Nicholas,et al. Aldehyde dehydrogenases: Widespread structural and functional diversity within a shared framework , 1993, Protein science : a publication of the Protein Society.
[230] J. Piatigorsky,et al. Aldehyde dehydrogenase-derived omega-crystallins of squid and octopus. Specialization for lens expression. , 1993, The Journal of biological chemistry.
[231] F. J. G. M. Van Kuijk,et al. Effects of ultraviolet light on the eye: role of protective glasses. , 1991 .
[232] M. Kaufman,et al. The 56 kDa androgen binding protein is an aldehyde dehydrogenase. , 1991, Biochemical and biophysical research communications.
[233] L. Birnbaum,et al. Metabolism of citral, an alpha,beta-unsaturated aldehyde, in male F344 rats. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[234] E. Ortiz-Sánchez,et al. ALDH as a Stem Cell marker in solid tumors. , 2018, Current stem cell research & therapy.
[235] J. Shih,et al. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. , 2013, Cancer letters.
[236] J Laterra,et al. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition , 2011, Oncogene.
[237] T. Münzel,et al. Nitrate reductase activity of mitochondrial aldehyde dehydrogenase (ALDH-2) as a redox sensor for cardiovascular oxidative stress. , 2010, Methods in molecular biology.
[238] B. Levi,et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. , 2009, Blood.
[239] V. Vasiliou,et al. ALDH3A1: a corneal crystallin with diverse functions. , 2007, Experimental eye research.
[240] N. Sládek. Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact , 2003, Journal of biochemical and molecular toxicology.
[241] P. Steinert,et al. Sjögren–Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene , 1996, Nature Genetics.
[242] T. Flynn,et al. Enzymology and Molecular Biology of Carbonyl Metabolism 4 , 1993, Advances in Experimental Medicine and Biology.
[243] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[244] M. Kastan,et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. , 1990, Blood.
[245] H J Edenberg,et al. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. , 1989, The Journal of clinical investigation.
[246] A Yoshida,et al. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. , 1984, Proceedings of the National Academy of Sciences of the United States of America.